马萨诸塞州马尔伯勒2024年11月26日 /美通社/ -- 近日，波士顿科学公司（纽约证券交易所代码：BSX）宣布已签订Intera Oncology® Inc ...

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide ...

11月25日，波士顿科学宣布同意收购输液泵制造商 Intera Oncology，具体金额未公开。预计将在2025年上半年完成交易。 据悉，Intera Oncology的核心产品有两款，一是肝动脉灌注泵（Intera ...

Boston Scientific Corporation BSX has entered into a definitive agreement to acquire Intera Oncology Inc., a Boston-based life science company. The acquisition expands the company’s ...

Boston Scientific’s acquisition of Intera Oncology is expected to close in the first half of 2025. Image credit: Michael Vi / Shutterstock. Boston Scientific has signed a definitive agreement to ...

Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

马萨诸塞州马尔伯勒 - 波士顿科学公司（纽约证券交易所代码：BSX）今天宣布达成最终协议，收购专门从事肝癌治疗设备和药物的Intera Oncology Inc.。此举旨在通过增加经美国食品和药物管理局批准的Intera 3000肝动脉输注泵和化疗药物氟尿嘧啶来增强波士顿科学的介入肿瘤学产品组合。

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

(RTTNews) - Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a privately held medical device company. Intera provides the ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...